Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operati... (ity KKR and NorthpointeCapital. We are e...)

HOME >> BIOLOGY >> TECHNOLOGY

Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer

Date:9/12/2007

ity, KKR and Northpointe Capital. We are extremely pleased to have Mark join and our team and help lead the charge of our expansion."

Mark Mirken, stated, "I have evaluated numerous opportunities over the past years and I am clearly convinced that Millennium presents a compelling opportunity. The unique product portfolio should provide incredible growth opportunities across a broad range of channels, both clinical and athletic. The emerging use of Resurgex's(R) patented targeted nutritional supplements technology to provide sustainable cellular improvement, which has been clinically demonstrated, has only begun to take shape. I believe the Company has an incredible future as the commercialization of its product portfolio expeditiously unfolds, clearly we are just at the tip of the implementation iceberg."

About Millennium Biotechnologies, Inc.: Millennium Biotechnologies, Inc. is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements. The company's flagship products, RESURGEX(R), RESURGEX Plus(R), and RESURGEX Select(R), are designed to assist in reducing fatigue and oxidative stress, maintaining lean muscle and immune support in immunocompromised conditions.

Millennium Biotechnologies, Inc. is a wholly owned subsidiary of Millennium Biotechnologies Group, Inc., a publicly-traded company (OTC Bulletin Board: MBTG). For more information about Millennium Biotechnologies, please contact Jerry Swon, Chief Executive Officer, at jswon@milbiotech.com or call (908) 604-2500. For more information about the Resurgex line of products visit http://www.resurgex.com.

This release includes certain forward-looking information that is based upon management's beliefs as well as on assumptions made by and data currently available to management. This information which has been, or in the future may be, included in reliance on the "safe harbor" provision
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. CPM Marketing Group, Announces Alliance for Healthcare Technology
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5

Post Your Comments:

Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operati...(ity KKR and NorthpointeCapital. We are e...)